ARO MEDICAL ApS - CVR: 34621608

2018, DKK

26.06.2019

Bruttoresultat

-696'

Primær drift

-846'

Årets resultat

-1.471'

Aktiver

282'

Kortfristede aktiver

282'

Egenkapital

-8.450'

Afkastningsgrad

-300 %

Soliditetsgrad

-2994 %

Likviditetsgrad

19 %

Resultat

26.06.2019

Årsrapport	2018 26.06.2019	2017 29.06.2018	2016 14.06.2017	2015 17.06.2016
Nettoomsætning
Bruttoresultat	-696.378	-180.222	-452.030	0
Resultat af primær drift	-845.841	-1.576.416	-1.847.095	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0
Finansielle indtægter	1.675	0	3.663	303.224
Finansieringsomkostninger	-813.416	-771.322	-633.661	-553.782
Andre finansielle omkostninger	0	0	0	0
Resultat før skat	-1.657.582	-2.347.738	-2.477.093	-1.975.442
Resultat	-1.471.497	-1.831.236	-1.932.133	-1.081.913
Forslag til udbytte	0	0	0	0

Aktiver

26.06.2019

Årsrapport	2018 26.06.2019	2017 29.06.2018	2016 14.06.2017	2015 17.06.2016
Kortfristede varebeholdninger	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	216.607	294.921	548.566	524.204
Likvider	65.604	514.560	273.826	1.919.635
Kortfristede aktiver	282.211	809.481	822.392	2.443.839
Immaterielle aktiver og goodwill	0	30.549.338	30.830.387	30.439.283
Finansielle anlægsaktiver	0	0	0	0
Materielle aktiver	0	0	0	0
Langfristede aktiver	0	30.549.338	30.830.387	30.439.283
Aktiver	282.211	31.358.819	31.652.779	32.883.122

Aktiver

26.06.2019

Passiver

26.06.2019

Årsrapport	2018 26.06.2019	2017 29.06.2018	2016 14.06.2017	2015 17.06.2016
Forslag til udbytte	0	0	0	0
Egenkapital	-8.449.732	17.558.812	19.390.047	21.322.181
Hensatte forpligtelser	0	6.012.292	6.243.813	6.296.369
Langfristet gæld til banker	0	0	0	0
Anden langfristet gæld	0	0	0	0
Leverandører af varer og tjenesteydelser	57.387	317.442	122.216	90.025
Kortfristede forpligtelser	1.502.803	1.336.208	261.727	127.303
Gældsforpligtelser	8.731.943	7.787.715	6.018.919	5.264.572
Forpligtelser	8.731.943	7.787.715	6.018.919	5.264.572
Passiver	282.211	31.358.819	31.652.779	32.883.122

Passiver

26.06.2019

Nøgletal

26.06.2019

Årsrapport	2018 26.06.2019	2017 29.06.2018	2016 14.06.2017	2015 17.06.2016
Afkastningsgrad	-299,7 %	-5,0 %	-5,8 %	Na.
Dækningsgrad	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.
Egenkapitals-forretning	17,4 %	-10,4 %	-10,0 %	-5,1 %
Payout-ratio	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-104,0 %	-204,4 %	-291,5 %	Na.
Soliditestgrad	-2.994,1 %	56,0 %	61,3 %	64,8 %
Likviditetsgrad	18,8 %	60,6 %	314,2 %	1.919,7 %

Resultat

26.06.2019

Gæld

26.06.2019

Årsrapport

26.06.2019

Nyeste:01.01.2018- 31.12.2018(offentliggjort: 26.06.2019)

Information om virksomhedens regnskabsklasse:The annual report of ARO Medical ApS for 2018 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to reporting class B entities and elective choice of certain provisions applying to reporting class C entities.

Beretning

26.06.2019

Dato for ledelsens godkendelse af årsrapporten:2019-06-26

Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:The Company's intangible assets are recognised at too high amounts in prior financial years, and the financial statements for 2017 do not give a true and fair view. Therefore, the error has been corrected as a material misstatement by restating comparatives and opening equity figures in the current-year financial statements. In consequence of the restatement, amortisation and impairment of intangible assets for 2017 have been adversely affected by DKK 30,549,338 and tax for the year 2017 has been positively affected by DKK 6,012,292. The profit/loss is adversely affected by a total of DKK 24,537,046. Intangible assets at 31 December 2017 have been adversely affected by DKK 30,549,338, provisions for deferred tax at 31 December 2017 have been adversely affected by DKK 6,012,292, and equity at 31 December 2017 has been adversely affected by DKK 24,537,046.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, the Board of Directors and the Executive Board have discussed and approved the annual report of ARO Medical ApS for the financial year 1 January - 31 December 2018.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The objective of the Company is to develop back implants and related activities.